All In MedTech

FDA Clearance Tracker · P970003-S106

VNS THERAPY SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 6, 2009 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P970003-S106
Device name
VNS THERAPY SYSTEM
Applicant location
Houston, TX
Received
Feb 5, 2009
Decided
Mar 6, 2009
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P970003

Device type

Device class
Class III

Every decision under product code LYJ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR CHANGING THE TRADE NAME OF THE VNS THERAPY PERENNIA MODEL 303 LEAD TO VNS THERAPY PERENNIADURA MODEL 303 LEAD.

Source documents

Other decisions for LivaNova USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.